Ever expanding rapid diagnostic products

Inverness Medical Innovations develops and manufactures rapid diagnostic products for use in preventive as well as interventional therapies.

Photo: Ever expanding rapid diagnostic products

Information from patients’ body fluids, or tissue, assists physicians to diagnose disease, as well as to measure a patient’s response to a specific therapy. Its range of clinical diagnostic products already includes, the well-known brands Clearview, Inverness Medical TestPack, Binax, Determine, BioStar, and many others. ‘Our high quality immunoassays in pregnancy testing and fertility, respiratory, enteric and infectious diseases, autoimmune disorders, osteoporosis, cancer and cardiology, have demonstrated proven efficiency in clinics, hospitals and laboratories internationally,’ the firm points out.

Currently, Inverness Medical Innovations reports that it is exploring opportunities to optimise the use of its technologies, as well as continually evaluating other technological advances, for development or acquisition, in a variety of medical/health areas.

14.11.2006

More on the subject:

Related articles

Photo

Sponsored • Produced in partnership with FUJIFILM Wako

Beta-D-glucan testing: More than a single result

Invasive fungal infections remain among the most challenging diagnoses in clinical microbiology. Beta-D-glucan (BDG) testing has emerged as a valuable non-invasive biomarker – but its true utility…

Photo

Interview • Resilience in healthcare

“We need redundancy at every level”

The threat of hybrid attacks in Germany is increasing. In this exclusive interview with MedLabPortal, DGKL CEO Jan Wolter highlights existing vulnerabilities and calls on policymakers to take action.

Photo

News • Acute myeloid leukaemia

Six-gene scoring system could help predict AML survival

Acute myeloid leukaemia (AML) has widely variable outcomes from one patient to the next. Now, researchers have created a new scoring system based on the activity of six different genes to help…

Subscribe to Newsletter